GNPX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Genprex (GNPX) Earnings Date & Reports

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

GNPX is expected to report earnings to fall 34.78% to -300 cents per share on March 29

Q4'23

Est.

$-3.00

Q3'23

Missed

by $4.50

Q2'23

Missed

by $5.07

Q1'23

Missed

by $6.24

Q4'22

Beat

by $0.02

The last earnings report on November 29 showed earnings per share of -459 cents, missing the estimate of -10 cents. With 63.23M shares outstanding, the current market capitalization sits at 3.62M.

View a ticker or compare two or three

Compare

GNPX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GNPX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of molecular therapies for cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3300 Bee Cave Road

Phone

+1 877 774-4679

Employees

Web

https://www.genprex.com